Redirecting in 3 seconds…
Recent Press Releases
- EVERSANA INTOUCH Wins Five Clio Awards
- EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally
- Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
- Yaral Pharma Partners with EVERSANA to Support the Commercialization of its Expanded Generics Portfolio
- Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection for the Treatment of T-cell Leukemia Across the United States
Categories
Archives